Status:
COMPLETED
Evaluation of DCTclock™ as a Cognitive Assessment Aid
Lead Sponsor:
Digital Cognition Technologies
Conditions:
Cognitive Function
Eligibility:
All Genders
55-95 years
Phase:
NA
Brief Summary
The overall objective of this study is to demonstrate the safety and effectiveness of DCTclock as an adjunctive tool for use by clinicians to evaluate cognitive function in adults aged 55-95.
Eligibility Criteria
Inclusion
- Men and women 55 to 95 years old.
Exclusion
- Ineligible for written informed consent.
- Physical impairment of the writing hand.
- Impaired manual dexterity.
- Impaired vision.
- Under the influence of recreational drugs or alcohol at the time of the visit.
- Current or recent participation in a clinical trial that includes the use of a drug or intervention to alter cognitive function.
- Recent cognitive testing.
Key Trial Info
Start Date :
July 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 21 2017
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT03238001
Start Date
July 11 2017
End Date
November 21 2017
Last Update
April 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Compass Research
Maitland, Florida, United States, 32751